FMP

FMP

Enter

SAN.PA - Sanofi

Financial Summary of Sanofi(SAN.PA), Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marke

photo-url-https://financialmodelingprep.com/image-stock/SAN.PA.png

Sanofi

SAN.PA

EURONEXT

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

86.89 EUR

1.66 (1.91%)

About

ceo

Mr. Paul Hudson

sector

Healthcare

industry

Drug Manufacturers - General

website

https://www.sanofi.com

exchange

EURONEXT

Description

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and ...

CIK

N/A

ISIN

FR0000120578

CUSIP

N/A

Address

54, Rue La BoEtie

Phone

33 1 53 77 40 00

Country

FR

Employee

86,088

IPO Date

Jan 3, 2000

Summary

CIK

-

Exchange

EURONEXT

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

-

ISIN

FR0000120578

Country

FR

Price

86.89

Beta

0.45

Volume Avg.

1.37M

Market Cap

108.73B

Shares

-

52-Week

80.6-105.18

DCF

135.85

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

20.21

P/B

-

Website

https://www.sanofi.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest SAN.PA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep